Posted by Michael Wonder on 30 Mar 2026
Eli Lilly pushes for NHS drug price increases in return for its UK investment
30 March 2026 - US pharmaceutical group ‘optimistic’ about reaching deal with British Government.
Britain must agree to regular increases in NHS drug prices and phase out a multibillion-pound rebate scheme if Eli Lilly is to resume investment in the UK, the US pharmaceutical group has said.
Patrik Jonsson, president of Lilly’s international businesses, told the FT the company was in talks with UK ministers and was feeling “optimistic” about reaching agreement by the summer for Britain to pay more for its medicines.
